[1] Nakanishi D, Tanio Y, Tagawa H,et al. An autopsy of a case of pulmonary hypertension secondary to pulmonary embolization of intrahepatic cholangiocarcinoma[J].Gan To Kagaku Ryoho,2014,40(4): 499-502. [2] Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study[J].Clin Gastroenterol Hepatol,2007,5(10): 1221-1228. [3] Yu TH, Yuan RH, Chen YL, et al. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression[J].Mod Pathol,2011, 24(6): 810-819. [4] Baheti AD, Tirumani SH, Shinagare AB, et al. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients[J].Abdom Imaging,2014,39(6): 1193-1201. [5] 程玉, 罗云藩, 廖锦岐, 等. 肝内胆管结石合并胆管癌 38 例临床分析[J].临床外科杂志,2012, 20(7): 473-475. [6] Nishiyama R, Shinoda M, Tanabe M, et al. Intrahepatic cholangiocarcinoma arising 33 years after excision of a choledochalcCyst:report of a case[J].Int Surg,2011,96(4): 320-325. [7] Zhou Q, Gong Y, Huang F, et al. Expression levels and significance of nuclear factor-κb and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma[J].Dig Surg,2013, 30(4-6): 309-316. [8] Li R, Yuan MX, Ma Ks, et al. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis[J].PLoS One,2014,9(5): e98612. [9] Shao YY, Huang CC, Liang PC, et al. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma[J].Asia Pac J Clin Oncol,2010,6(2): 80-88. [10] Labgaa I, Carrasco-Avino G, Fiel MI, et al. Pancreatic recurrence of intrahepatic cholangiocarcinoma: Case report and review of the literature[J].World J Gastrointest Surg,2014,6(4): 65-69. [11] 王广义, 王英超, 孙晓东.肝内胆管结石合并胆管癌[J].世界华人消化杂志,2012,20(34): 3336-3339. [12] Zhang Gw, Lin Jh, Qian Jp, et al. Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis-associated intrahepatic cholangiocarcinoma[J].J Surg Oncol,2014, 109(5): 494-499. [13] Ishikawa A, Sasaki M, Ohira S, et al. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis[J].Lab Invest,2004, 84(5): 629-638. [14] Kuroki T, Tajima Y, Kanematsu T. Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms[J].J Hepatobiliary Pancreat Surg,2005,12(6): 463-466.
2016, Vol. 33 
